| 0 (0%) | 12-26 20:12 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 61.63 | 1-year : | 63.63 |
| Resists | First : | 52.77 | Second : | 54.47 |
| Pivot price | 51.63 |
|||
| Supports | First : | 50 | Second : | 41.6 |
| MAs | MA(5) : | 50.82 |
MA(20) : | 52.05 |
| MA(100) : | 45.57 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 7.1 |
D(3) : | 11.2 |
| RSI | RSI(14): 45.7 |
|||
| 52-week | High : | 54.47 | Low : | 33.56 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ PTH ] has closed above bottom band by 18.5%. Bollinger Bands are 6.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 50.92 - 51.17 | 51.17 - 51.42 |
| Low: | 49.62 - 49.93 | 49.93 - 50.25 |
| Close: | 49.94 - 50.44 | 50.44 - 50.93 |
Fri, 26 Dec 2025
Postoperative Hungry Bone Syndrome in Hyperparathyroidism: Insights from South Africa - BIOENGINEER.ORG
Mon, 22 Dec 2025
Understanding the Setup: (PTH) and Scalable Risk - Stock Traders Daily
Mon, 22 Dec 2025
New once-a-day pill aims to replace daily injections for rare calcium disorder - Stock Titan
Fri, 31 Oct 2025
PTH Test: Normal Range, Purpose & Parathyroid Hormone Levels - Metropolis Healthcare
Tue, 02 Sep 2025
Switch From rhPTH1-84 to TransCon PTH With Individual Dose Adjustment in Adult Hypoparathyroidism - Endocrine Society
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |